Evidence map›Paper›PMID 40785793›Full record

ArticleCurrent research in microbial sciences2025

Antibacterial metabolites from a heterobranchia-associated bacteria and their prey from Bali, Indonesia.

Rhesi Kristiana, Ni Kadek Dita Cahyani, Yang Jin, I Wayan Mudianta, Fadillaisyia Riandani Putri, Kharisma Ayu Zeina Halisah, Meng-Xue Wang, Yue-Wei Guo, Xu-Wen Li, Ocky Karna Radjasa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in microbial sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rhesi KristianaMERO Foundation (Indonesian Marine Education and Research Organisation), Karangasem, Bali, Indonesia.
Ni Kadek Dita CahyaniBiology Department, Faculty of Science and Mathematics, Diponegoro University, Semarang, Indonesia.
Yang JinState Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
I Wayan MudiantaStudy Program of Applied Chemistry, Faculty of Mathematics and Natural Sciences, Ganesha University of Education, Bali, Indonesia.
Fadillaisyia Riandani PutriMERO Foundation (Indonesian Marine Education and Research Organisation), Karangasem, Bali, Indonesia.
Kharisma Ayu Zeina HalisahMERO Foundation (Indonesian Marine Education and Research Organisation), Karangasem, Bali, Indonesia.
Meng-Xue WangShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
Yue-Wei GuoShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
Xu-Wen LiState Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Ocky Karna RadjasaResearch Organization of Earth Sciences and Maritime, National Research and Innovation Agency (BRIN), Jakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine-associated bacteria serve as a significant source of bioactive natural products for drug discovery efforts. The microbial symbionts of heterobranchs and their prey represent a promising source of bioactive compounds with potential applications as pharmaceutical agents. This study aimed to evaluate the diversity of associated microbes of heterobranchs and their prey that were obtained from one of marine biodiversity hotspots. The next step involved employing in vitro antibacterial screening of the organic extracts of the bacterial strains to determine the most potent ones. Microbiome study revealed that

Indexed as

HeterobranchiaMarine-associated bacteriaRuegeria sp.

Identifiers

PMID40785793
PMCPMC12332862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.